Lysaker, Norway, 8 February, 2012.
In accordance with the Power of Attorney given at the general meeting on April 27, 2010, the Board of PCI Biotech Holding ASA has allocated 135,000 share options to key personnel in the company.
The share options have a term of 1 to 3 years. Strike price for the share options is NOK 37.02 per share, equal to the average price of all trades the 5 last days with trade prior to allocation.
The following share options were allocated to the primary insiders (new holding of shares and share options are given in brackets);
* CEO Per Walday has been allocated 16,000 share options (12,000 shares, 226,000 share options).
* CFO Bernt-Olav Røttingsnes has been allocated 25,000 share options (0 shares, 96,000 share options).
A total of 108,000 options have been allocated to other key employees.
For further information, please contact:
Per Walday
CEO
In accordance with the Power of Attorney given at the general meeting on April 27, 2010, the Board of PCI Biotech Holding ASA has allocated 135,000 share options to key personnel in the company.
The share options have a term of 1 to 3 years. Strike price for the share options is NOK 37.02 per share, equal to the average price of all trades the 5 last days with trade prior to allocation.
The following share options were allocated to the primary insiders (new holding of shares and share options are given in brackets);
* CEO Per Walday has been allocated 16,000 share options (12,000 shares, 226,000 share options).
* CFO Bernt-Olav Røttingsnes has been allocated 25,000 share options (0 shares, 96,000 share options).
A total of 108,000 options have been allocated to other key employees.
For further information, please contact:
Per Walday
CEO
Email: pw@pcibiotech.no
Mobil: +47 917 93 429
Mobil: +47 917 93 429
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.